Drug Profile
Research programme: retinoic acid derivatives - sigma-tau
Alternative Names: ST 1898Latest Information Update: 29 Sep 2010
Price :
$50
*
At a glance
- Originator sigma-tau SpA
- Class Retinoids; Skin disorder therapies
- Mechanism of Action Apoptosis stimulants; Retinoic acid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Acne
Most Recent Events
- 05 Mar 2007 Preclinical trials in Acne in Italy (unspecified route)